Heterogeneity of amiodarone‐induced thyrotoxicosis: evaluation of colour‐flow Doppler sonography in predicting therapeutic response
Abstract
Abstract Background: Amiodarone‐induced thyrotoxicosis (AIT) presents a therapeutic challenge because of its resistance to standard antithyroid therapy. In iodine‐deplete environments, colour‐flow Doppler sonography (CFDS) has allowed distinction between two types of AIT: (i) Type I AIT, associated with increased vascularity (CFDS I−III) and response to thionamide antithyroid drug and (ii) type II AIT, with no/little thyroid vascularity (CFDS 0) and prednisolone responsiveness. Aim: To clarify if CFDS patterns correlated with treatment outcomes in a retrospective study of 24 patients with AIT in an iodine‐replete environment. Methods: Medical records of patients who presented to a teaching hospital between January 1998 to December 2000 were reviewed. Results of CFDS, ultrasound measurement of thyroid size and technetium scanning of the thyroid were correlated with treatment responses, especially prednisolone responsiveness. Results: Thirteen of 24 patients showed CFDS 0. Twelve of these 13 were evaluable for prednisolone responsiveness, of whom seven (58%) were prednisolone‐responsive. Of 11 patients with CFDS I−III, four (36%) responded to antithyroid medication alone and only one of seven (14%) was prednisolone‐responsive. Euthyroidism was achieved twice as rapidly in patients with CFDS 0 than those with CFDS I‐III. Because of medical treatment failure, seven patients, from both CFDS groups, required urgent near‐total thyroidectomy which was successful and uncomplicated in all cases. Conclusions: CFDS is useful in the management of AIT because CFDS 0 correlates better with prednisolone response (58%) than CFDS I−III (14%). However, unlike experience in iodine‐deficient regions, the results of the present study revealed that treatment responses to thionamide or prednisolone were heterogeneous within uniform CFDS patterns. Thus, prednisolone‐responsiveness was not consistently predicted by CFDS 0, but the presence of flow appeared to correlate with non‐response to prednisolone. (Intern Med J 2003; 33: 420−426)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Deaths from ventricular fibrillation have occurred after stopping amiodarone in patients with AIT.
“Deaths from ventricular fibrillation have occurred after stopping amiodarone in patients with AIT (584).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [584]
However, CFDS is not universally useful for distinguishing AIT subtypes.
“However, CFDS is not universally useful (584,589).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [584]
Cites
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M. R., Dorian, P., Connolly, S. J., Eisenberg, M. J., Green, M. S., Kuś, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,142 · see citing works
The Effects of Amiodarone on the Thyroid
Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0427 · Cited by 559 · see citing works
McGahan, J. P., & Goldberg, B. B. (1998) · Ultrasound Quarterly · doi:10.1097/00013644-199809000-00006 · Cited by 297 · see citing works
Bartalena, L., Brogioni, S., Grasso, L., Bogazzi, F., Burelli, A., & Martino, E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768854 · Cited by 234 · see citing works
The Effects of Amiodarone on the Thyroid
Martino, E. (2001) · Endocrine Reviews · doi:10.1210/er.22.2.240 · Cited by 226 · see citing works
Color-flow Doppler sonography in Graves disease: "thyroid inferno"
Ralls, P., Mayekawa, D. S., Lee, K. P., Colletti, P., Radin, D., BOSWELL, W. D., & Halls, J. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.4.781 · Cited by 221 · see citing works
Bogazzi, F., Bartalena, L., Brogioni, S., Mazzeo, S., Vitti, P., Burelli, A., Bartolozzi, C., & Martino, E. (1997) · Thyroid · doi:10.1089/thy.1997.7.541 · Cited by 190 · see citing works
Serum interleukin-6 in amiodarone-induced thyrotoxicosis
Bartalena, L., Grasso, L., Brogioni, S., Aghini-Lombardi, F., Braverman, L. E., & Martino, E. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106631 · Cited by 172 · see citing works
Amiodarone-Induced Thyrotoxicosis
Daniels, G. H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7119 · Cited by 159 · see citing works
Eaton, S. E. M., Euinton, H. A., Newman, C. M., Weetman, A. P., & Bennet, W. M. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01457.x · Cited by 139 · see citing works
Forbes, A. (1994) · Postgraduate Medical Journal · doi:10.1136/pgmj.70.830.942-c · Cited by 135 · see citing works
Pathology of the Thyroid in Amiodarone-Associated Thyrotoxicosis
Smyrk, T. C., Goellner, J. R., BRENNAN, M. D., & Carney, J. A. (1987) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198703000-00004 · Cited by 127 · see citing works
Iodine Kinetic Studies during Amiodarone Treatment*
Rao, R. H., McCREADY, V. R., & Spathis, G. S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-3-563 · Cited by 114 · see citing works
Successful Treatment of Amiodarone-Induced Thyrotoxicosis
Osman, F., Franklyn, J. A., Sheppard, M. C., & Gammage, M. D. (2002) · Circulation · doi:10.1161/circ.105.11.1275 · Cited by 96 · see citing works
Bogazzi, F., Bartalena, L., Cosci, C., Brogioni, S., Dell'Unto, E., Grasso, L., Aghini-Lombardi, F., Rossi, G., Pinchera, A., Braverman, L. E., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021874 · Cited by 89 · see citing works
Treatment of hyperthyroidism with a combination of methimazole and cholestyramine
Mercado, M., Mendoza‐Zubieta, V., Bautista-Osorio, R., & Monteros, A. L. E. D. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784067 · Cited by 67 · see citing works
IS HUMORAL THYROID AUTOIMMUNITY RELEVANT IN AMIODARONE IODINE‐INDUCED THYROTOXICOSTS (AIIT)?
Martino, E., Macchia, E., Aghini-Lombardi, F., ANTONELLI, A., Lenziardi, M., Concetti, R., Fenzi, G. F., Baschieri, L., & Pinchera, A. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01658.x · Cited by 61 · see citing works
Surgical Management of Amiodarone‐associated Thyrotoxicosis: Too Risky or Too Effective?
Hamoir, E., Meurisse, M., Deféchereux, T., Joris, J. L., Vivario, J., & Hennen, G. P. (1998) · World Journal of Surgery · doi:10.1007/pl00024613 · Cited by 54 · see citing works
Wiersinga, W. M. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60709-7_10 · Cited by 53 · see citing works
Newnham, H. H., Topliss, D. J., GRAND, B. A. L., et al. (1988) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1988.tb02237.x · Cited by 52 · see citing works
Self-citationREFRACTORY AMIODARONE‐ASSOCIATED THYROTOXICOSIS: AN INDICATION FOR THYROIDECTOMY
Claxton, S., Sinha, S. N., Donovan, S., et al. (2000) · Australian and New Zealand Journal of Surgery · doi:10.1046/j.1440-1622.2000.01780.x · Cited by 48 · see citing works
Amiodarone-Induced Thyroid Dysfunction
Iudica-Souza, C., & Burch, H. B. (1999) · The Endocrinologist · doi:10.1097/00019616-199905000-00008 · Cited by 35 · see citing works
Surgical management of amiodarone‐associated thyrotoxicosis
Gough, I. R., & Gough, J. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04320.x · Cited by 23 · see citing works
Amiodarone-Induced Thyrotoxicosis
Tavackoli, S., Stouffer, G. A., Sheahan, R. G., et al. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199708000-00011 · Cited by 8 · see citing works
The place of amiodarone: an overview of the four recent large controlled trials
Campbell, T. J. (1997) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1997.tb00968.x · Cited by 6 · see citing works
Tavackoli, S., Stouffer, G. A., & Sheahan, R. G. (1997) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40175-2 · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“These patients are frequently referred to as having ‘‘mixed’’ types of AIT.”
BackgroundInfluentialLoy, M., Perra, E., Melis, A., Cianchetti, M. E., Piga, M., Serra, A., Pinna, G., & Mariotti, S. (2007) · Acta Radiologica · doi:10.1080/02841850701342138 · Cited by 55 · see citing works
Macedo, T. A. A., Chammas, M. C., Jorge, P. T., Souza, L. P., Farage, L., Watanabe, T., Santos, V. A., & Cerri, G. G. (2007) · Acta Radiologica · doi:10.1080/02841850701280791 · Cited by 24 · see citing works
- Authors
- Wong, R., Cheung, W., Stockigt, J. R., & Topliss, D. J.
- Affiliations
- The Alfred Hospital (AU)
- Corresponding author
- Topliss, D. J.
- ORCID
- Topliss, D. J.
- Venue
- Internal Medicine Journal
- Publisher
- Wiley
- Published
- 2003-09
- Volume
- 33
- Issue
- 9-10
- Pages
- 420-426
- ISSN
- 1444-0903 (ISSN-L)
- 1445-5994
- OpenAlex
- W2077070523
- Cited by
- 32
- References
- 26
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 1
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Internal Medicine Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Ophthalmology and Eye Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- amiodarone-induced thyrotoxicosis, thyroid vascularity, treatment response prediction, near-total thyroidectomy
- MeSH terms
- Adult, Aged, Amiodarone, Anti-Arrhythmia Agents, Female, Glucocorticoids, Humans, Male, Middle Aged, Prednisolone, Thyroidectomy, Thyrotoxicosis, Ultrasonography, Doppler, Color
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review